Dexamethasone Tablet
FDA Label NDC 0904-7266

23 label sections · Submitted to the FDA by Major Pharmaceuticals · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Major Pharmaceuticals for the product Dexamethasone (NDC 0904-7266). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, indications and usage, contraindications, general, cardio-renal, endocrine, gastrointestinal, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

MAJOR®

NDC 0904-7266-61

Unit Dose

Dexamethasone

Tablets, USP

4 mg

100 TABLETS (10 x 10)

Rx only

4mg Carton Label (574d26cb 6ade 4619 Be52 Ef855081c8da 01)

4mg Carton Label (574d26cb 6ade 4619 Be52 Ef855081c8da 01)

MAJOR®

NDC 0904-7267-61

Unit Dose

Dexamethasone

Tablets, USP

6 mg

100 TABLETS (10 x 10)

Rx only

6mg Carton Label (574d26cb 6ade 4619 Be52 Ef855081c8da 00)

6mg Carton Label (574d26cb 6ade 4619 Be52 Ef855081c8da 00)

* Please review the disclaimer below.